Evaluation of treatment of the ethmoid sinuses with the Ethmoid Sinus Spacer and Access system
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
14
Ethmoid Sinus Spacer and Access System used for the local delivery of Kenalog-40
Georgia Nasal and Sinus Institute
Savannah, Georgia, United States
Occurrence of Adverse Events at the Time of the Procedure and Cumulatively up to 6 Weeks Post-implant
Time frame: Procedural and 6 weeks post-implant
Efficacy: Improvement in Ethmoid Sinus Health as Demonstrated by CT Scan and Quality-of-life Measures
Time frame: 1 wk, 2wk, 4wk, 6wk
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.